Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorDurankuş, Ferit
dc.contributor.authorŞenkal, E.
dc.contributor.authorÇam, Sebahat
dc.contributor.authorPotas, Nihan
dc.contributor.authorAlbayrak, Yakup
dc.contributor.authorNural, C.
dc.contributor.authorErel, Özcan
dc.date.accessioned2022-05-11T14:05:08Z
dc.date.available2022-05-11T14:05:08Z
dc.date.issued2021
dc.identifier.issn1328-8067
dc.identifier.urihttps://doi.org/10.1111/ped.14406
dc.identifier.urihttps://hdl.handle.net/20.500.11776/4905
dc.description.abstractBackground: In this study, we assessed thiol/disulfide homeostasis (TDH) parameters and ischemia-modified albumin (IMA) levels in children with irritable bowel syndrome (IBS) compared with healthy children. Methods: Fifty-six children with IBS and 53 healthy children were included in the study after assessment of inclusion and exclusion criteria. Plasma thiol/disulfide and IMA levels were compared between children with and without IBS. Results: The mean values of native thiol, total thiol, and disulfide were 343.779 (Formula presented.) 138.654 ?mol/L, 365.398 ± 140.148 ?mol/L, and 23.190 ± 4.978 ?mol/L, respectively, in the IBS group and 409.908 ± 69.288 ?mol/L, 433.481 ± 76.891 ?mol/L, and 20.090 ± 4.252 ?mol/L, respectively, in the control group. Native thiol and total thiol values were significantly reduced in the IBS group compared with the control group. The mean IMA values were 0.835 ± 0.083 (g/L) and 0.778 ± 0.072 in the IBS and control groups, respectively. The IMA value was significantly increased in the IBS group. Conclusion: Impaired thiol/disulfide homeostasis and increased IMA levels can be considered etiological factors in children with IBS. © 2020 Japan Pediatric Societyen_US
dc.language.isoengen_US
dc.publisherJohn Wiley and Sons Incen_US
dc.identifier.doi10.1111/ped.14406
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectirritable bowel syndromeen_US
dc.subjectoxidative stressen_US
dc.subjectthiolen_US
dc.subjectdisulfideen_US
dc.subjectischemia modified albuminen_US
dc.subjectthiolen_US
dc.subjectbiological markeren_US
dc.subjectdisulfideen_US
dc.subjecthuman serum albuminen_US
dc.subjectischemia-modified albuminen_US
dc.subjectserum albuminen_US
dc.subjectthiol derivativeen_US
dc.subjectadolescenten_US
dc.subjectalbumin blood levelen_US
dc.subjectArticleen_US
dc.subjectblood levelen_US
dc.subjectconstipationen_US
dc.subjectcontrolled studyen_US
dc.subjectdiarrheaen_US
dc.subjectfemaleen_US
dc.subjecthomeostasisen_US
dc.subjecthumanen_US
dc.subjectirritable colonen_US
dc.subjectmajor clinical studyen_US
dc.subjectmaleen_US
dc.subjectoxidative stressen_US
dc.subjectpathogenesisen_US
dc.subjectchilden_US
dc.subjecthomeostasisen_US
dc.subjectirritable colonen_US
dc.subjectmetabolismen_US
dc.subjectBiomarkersen_US
dc.subjectChilden_US
dc.subjectDisulfidesen_US
dc.subjectHomeostasisen_US
dc.subjectHumansen_US
dc.subjectIrritable Bowel Syndromeen_US
dc.subjectOxidative Stressen_US
dc.subjectSerum Albuminen_US
dc.subjectSerum Albumin, Humanen_US
dc.subjectSulfhydryl Compoundsen_US
dc.titleAltered thiol/disulfide homeostasis and ischemia-modified albumin levels in children with irritable bowel syndromeen_US
dc.typearticleen_US
dc.relation.ispartofPediatrics Internationalen_US
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Ruh Sağlığı ve Hastalıkları Ana Bilim Dalıen_US
dc.identifier.volume63en_US
dc.identifier.issue3en_US
dc.identifier.startpage300en_US
dc.identifier.endpage305en_US
dc.institutionauthorAlbayrak, Yakup
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid55315126400
dc.authorscopusid55175886400
dc.authorscopusid8240771400
dc.authorscopusid36523620300
dc.authorscopusid29067508300
dc.authorscopusid57195410600
dc.authorscopusid7003566828
dc.identifier.wosWOS:000629305300001en_US
dc.identifier.scopus2-s2.0-85102500015en_US
dc.identifier.pmid32713058en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster